Gufic Biosciences Q1 Results Live: Profit Rises by 1.13% YoY

Gufic Biosciences Q1 Results Live : Gufic Biosciences declared their Q1 results on 14 Aug, 2024. The company reported a revenue increase of 4% year-over-year (YoY) and a profit increase of 1.13% YoY. Compared to the previous quarter, the revenue grew by 4.01% and the profit increased by 4.04%.

The company's Selling, General, and Administrative (SG&A) expenses saw a decline of 1.88% quarter-over-quarter (QoQ), but increased significantly by 24.27% on a year-over-year basis. This indicates a mixed performance in terms of cost management.

Operating income for Gufic Biosciences was up by 5.32% QoQ and showed a modest increase of 0.75% YoY. This improvement in operating income reflects the company's efforts to enhance operational efficiency.

Earnings per share (EPS) for Q1 stood at ₹2.08, which represents a decline of 2.35% YoY. The decrease in EPS could be attributed to increased operating costs and other financial factors affecting the bottom line.

Gufic Biosciences has delivered a -1.93% return in the past week, a 4.91% return over the last six months, and a 9.75% year-to-date (YTD) return. These figures indicate varying levels of investor confidence and market performance over different time frames.

As of now, Gufic Biosciences has a market capitalization of ₹3,484.71 Crores. The company's 52-week high and low are ₹386.95 and ₹237.35, respectively, showcasing the stock's trading range over the past year.